Pura Vida Investments, LLC Mirati Therapeutics, Inc. Transaction History

Pura Vida Investments, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$59.5 - $86.7 $1.19 Million - $1.73 Million	20,000 New	20,000 $1.4 Million
Q1 2022 May 16, 2022	SELL	$75.82 - $150.97 $369,395 - $735,525	-4,872 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$132.01 - $190.29 $1.34 Million - $1.93 Million	-10,128 Reduced 67.52%	4,872 $715,000
Q3 2021 Nov 15, 2021	SELL	$132.13 - $177.45 $3.24 Million - $4.35 Million	-24,522 Reduced 62.05%	15,000 $2.65 Million
Q2 2021 Aug 16, 2021	BUY	$144.0 - $179.73 $1.34 Million - $1.67 Million	9,280 Added 30.69%	39,522 $6.38 Million

Q1 2021 May 12, 2021	BUY	$158.92 - $221.61 $3.22 Million - $4.49 Million	20,242 Added 202.42%	30,242 $5.18 Million
Q4 2020 Feb 16, 2021	BUY	$162.05 - $240.27 $1.62 Million - $2.4 Million	10,000 New	10,000 $2.2 Million

3.57M

36.6K

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Pura Vida Investments, LLC with notifications on news.